380 related articles for article (PubMed ID: 26034207)
1. Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.
Sido JM; Nagarkatti PS; Nagarkatti M
J Leukoc Biol; 2015 Sep; 98(3):435-47. PubMed ID: 26034207
[TBL] [Abstract][Full Text] [Related]
2. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties.
Hegde VL; Nagarkatti M; Nagarkatti PS
Eur J Immunol; 2010 Dec; 40(12):3358-71. PubMed ID: 21110319
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone potentiates myeloid-derived suppressor cell function in prolonging allograft survival through nitric oxide.
Liao J; Wang X; Bi Y; Shen B; Shao K; Yang H; Lu Y; Zhang Z; Chen X; Liu H; Wang J; Chu Y; Xue L; Wang X; Liu G
J Leukoc Biol; 2014 Nov; 96(5):675-84. PubMed ID: 24948701
[TBL] [Abstract][Full Text] [Related]
5. Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3⁺ regulatory T cells in skin-transplanted mice.
Gajardo T; Morales RA; Campos-Mora M; Campos-Acuña J; Pino-Lagos K
Immunology; 2015 Sep; 146(1):81-8. PubMed ID: 25988395
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors.
Gaffal E; Cron M; Glodde N; Tüting T
Allergy; 2013 Aug; 68(8):994-1000. PubMed ID: 23889474
[TBL] [Abstract][Full Text] [Related]
7. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.
Springs AE; Karmaus PW; Crawford RB; Kaplan BL; Kaminski NE
J Leukoc Biol; 2008 Dec; 84(6):1574-84. PubMed ID: 18791168
[TBL] [Abstract][Full Text] [Related]
8. Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model.
Pandey R; Hegde VL; Nagarkatti M; Nagarkatti PS
J Pharmacol Exp Ther; 2011 Sep; 338(3):819-28. PubMed ID: 21673072
[TBL] [Abstract][Full Text] [Related]
9. Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo.
Cai S; Choi JY; Borges TJ; Zhang H; Miao J; Ichimura T; Li X; Xu S; Chu P; Eskandari SK; Allos H; Alhaddad JB; Muhsin SA; Yatim K; Riella LV; Sage PT; Chandraker AK; Azzi JR
Sci Rep; 2020 Aug; 10(1):14249. PubMed ID: 32859934
[TBL] [Abstract][Full Text] [Related]
10. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response.
McKallip RJ; Nagarkatti M; Nagarkatti PS
J Immunol; 2005 Mar; 174(6):3281-9. PubMed ID: 15749859
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.
Robinson RH; Meissler JJ; Breslow-Deckman JM; Gaughan J; Adler MW; Eisenstein TK
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1239-50. PubMed ID: 23824763
[TBL] [Abstract][Full Text] [Related]
12. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
13. Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.
McKallip RJ; Lombard C; Martin BR; Nagarkatti M; Nagarkatti PS
J Pharmacol Exp Ther; 2002 Aug; 302(2):451-65. PubMed ID: 12130702
[TBL] [Abstract][Full Text] [Related]
14. Activation of CB
Joffre J; Yeh CC; Wong E; Thete M; Xu F; Zlatanova I; Lloyd E; Kobzik L; Legrand M; Hellman J
J Immunol; 2020 Jun; 204(12):3339-3350. PubMed ID: 32385136
[No Abstract] [Full Text] [Related]
15. Δ9-Tetrahydrocannabinol-mediated epigenetic modifications elicit myeloid-derived suppressor cell activation via STAT3/S100A8.
Sido JM; Yang X; Nagarkatti PS; Nagarkatti M
J Leukoc Biol; 2015 Apr; 97(4):677-88. PubMed ID: 25713087
[TBL] [Abstract][Full Text] [Related]
16. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of islet engraftment and achievement of long-term islet allograft survival by Toll-like receptor 4 blockade.
Giovannoni L; Muller YD; Lacotte S; Parnaud G; Borot S; Meier RP; Lavallard V; Bédat B; Toso C; Daubeuf B; Elson G; Shang L; Morel P; Kosco-Vilbois M; Bosco D; Berney T
Transplantation; 2015 Jan; 99(1):29-35. PubMed ID: 25340601
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.
Xie J; Xiao D; Xu Y; Zhao J; Jiang L; Hu X; Zhang Y; Yu L
Oncotarget; 2016 Feb; 7(6):6436-47. PubMed ID: 26824325
[TBL] [Abstract][Full Text] [Related]
19. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts.
Kemter AM; Scheu S; Hüser N; Ruland C; Schumak B; Findeiß M; Cheng Z; Assfalg V; Arolt V; Zimmer A; Alferink J
Life Sci; 2015 Oct; 138():29-34. PubMed ID: 25744392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
